Krystal Biotech (KRYS) P/E (2017 - 2026)
Krystal Biotech (KRYS) P/E from Oct 2, 2017 to Jul 21, 2026. The TTM Krystal Biotech (KRYS) P/E is 43.90. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Krystal Biotech (KRYS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 43.90 | +25.71% |
| 2025 | 34.92 | -30.91% |
| 2024 | 50.54 | -153.91% |
| 2023 | -93.76 | +504.88% |
| 2022 | -15.50 | -33.19% |
| 2021 | -23.20 | -35.47% |
| 2020 | -35.95 | -24.96% |
| 2019 | -47.91 | +115.90% |
| 2018 | -22.19 | +8.60% |
| 2017 | -20.44 | N/A |
Comparison Krystal Biotech (KRYS) P/E with competitors
Krystal Biotech (KRYS) P/E is 43.90.